| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/19/2002 | US20020133008 Sexual disorder therapy; cardiovascular disorders; antidiabetic agents; gastrointestinal disorders |
| 09/19/2002 | US20020133007 Potato and corn crops |
| 09/19/2002 | US20020132992 Reagent system and method for increasing the luminescence of lanthanide(III) macrocyclic complexes |
| 09/19/2002 | US20020132826 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/19/2002 | US20020132824 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 09/19/2002 | US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/19/2002 | US20020132819 Phosphoryl derivatives of purines; treatment of bone related disorders and cancer |
| 09/19/2002 | US20020132812 Oral hypoglycaemic agents |
| 09/19/2002 | US20020132811 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
| 09/19/2002 | US20020132319 Peptide mutant of human ERAB or HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 09/19/2002 | DE10112768A1 New heterocyclic-substituted phenyl compounds, are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, restenosis or tumor diseases |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/18/2002 | EP1241176A1 Purine derivatives for the treatment of ischemia |
| 09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
| 09/18/2002 | EP1241168A1 Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them |
| 09/18/2002 | EP1240168A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/18/2002 | EP1240158A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1104762B1 Substituted imidazo[1,2a]azines as selective inhibitors of cox-2 |
| 09/18/2002 | EP0994881B1 Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes |
| 09/18/2002 | EP0944386B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/18/2002 | EP0858461B1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | EP0764158B1 Benzopyrans and their use as therapeutic agents |
| 09/18/2002 | EP0757681B1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 09/18/2002 | CN1370176A Subsstituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
| 09/18/2002 | CN1370169A Substituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370168A Novel spiro compounds |
| 09/18/2002 | CN1370167A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370166A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370165A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370164A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370163A Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives |
| 09/18/2002 | CN1370160A Substituted heterocyclyl-2h-chromenes |
| 09/18/2002 | CN1091123C Process for producing and purifying perylene-3,4-dicarboxylic acid imides |
| 09/17/2002 | US6452008 Pyridone derivatives and process for preparing the same |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451811 Herpes virus |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/17/2002 | US6451809 Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands |
| 09/17/2002 | US6451805 Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451796 Fused pyrazine compounds |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |
| 09/16/2002 | CA2376738A1 Purine derivatives for the treatment of ischemia |
| 09/12/2002 | WO2002070739A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070521A1 Novel metalloproteinase inhibitor derivatives, method for preparing same and pharmaceutical compositions containing them |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | WO2002070480A1 Glutarimide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070439A2 Amination process |
| 09/12/2002 | WO2002069968A1 New use |
| 09/12/2002 | WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders |
| 09/12/2002 | WO2002053099A3 Methods and compositions for treating periodontal disease |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001038327A3 Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates |
| 09/12/2002 | WO2001012600A9 INHIBITORS OF FACTOR Xa |
| 09/12/2002 | US20020128490 Amination process |
| 09/12/2002 | US20020128281 Treatment of malignant tumors. |
| 09/12/2002 | US20020128265 CRF receptor antagonists and methods relating thereto |
| 09/12/2002 | US20020128232 Heterocyclic angiogenesis inhibitors |
| 09/12/2002 | US20020128208 Such as 4-benzoylamino-(2-(2-hydroxyethyl)-piperazin-1-yl-methyl)-phenyl)-benzene -sulfonamide; for treatment of hypertension; treatment of kidney disorders |
| 09/12/2002 | US20020127756 For producing assembly such as nanostructured units selected from the group comprising nanoparticles, like metal, semiconductor, or core/shell semiconductor nanoparticles, nanowires, nanotubes, nanobelts, and electrodes |
| 09/12/2002 | CA2440100A1 New use |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | CA2439581A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders |
| 09/12/2002 | CA2439176A1 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/11/2002 | EP1238979A1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/11/2002 | EP0823909B1 Novel heterocyclic chemistry |
| 09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 09/11/2002 | CN1368891A Moxilfloxacin formulation containing common salt |
| 09/11/2002 | CN1368502A Process for preparing general alooerine |
| 09/11/2002 | CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 09/11/2002 | CN1090630C Preparation of [1S-[1a, 2b, 3b, 4a(S*)]]-4-[7-[1-(3-chloro-2-thienyl)methyl]propyl]amino]-3H-imidazo [4,5-b] pyridin-3-yl]-N-ethyl-2,3-dyhydroxy pentamethylene formamide |
| 09/11/2002 | CN1090628C New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2002 | US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/10/2002 | US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448258 Heterocyclic amine compounds |
| 09/10/2002 | US6448257 Tricyclic carboxamides contain a piperazine or piperidine moiety; antiinflammatory agents; heart and kidney conditions |